T cell depletion of allogeneic stem cell grafts with anti-CD 52 monoclonal antibodies: the Ulm experience from 1983-1999. (Q34062753)

30 July 2017

1 reference

title

T cell depletion of allogeneic stem cell grafts with anti-CD 52 monoclonal antibodies: the Ulm experience from 1983-1999. (English)

1 reference

30 July 2017

D Bunjes

1

1 reference

30 July 2017

publication date

1 October 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

23

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

151-162

1 reference

Treatment of murine leukaemia with x-rays and homologous bone marrow. II

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Marrow transplantation from related donors other than HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Marrow transplantation from unrelated volunteer donors

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Ex-vivo treatment of donor bone marrow with anti-T-cell immunotoxins for prevention of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

The CAMPATH-1 antigen (CDw52)

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Characterization of the CAMPATH-1 (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

T-cell depletion versus methotrexate as GvHD-prophylaxis in allogeneic bone marrow transplantation for leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Evidence for the involvement of host-derived OKT8-positive T cells in the rejection of T-depleted, HLA-identical bone marrow grafts.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Remission Induction in Patients with Lymphoid Malignancies Using Unconjugated CAMPATH-1 Monoclonal Antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. European Group for Blood and Marrow Transplantation (EBMT)

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Preparation and evaluation of the rhenium-188-labelled anti-NCA antigen monoclonal antibody BW 250/183 for radioimmunotherapy of leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Duration of filgrastim mobilization and apheresis yield of CD34+ progenitor cells and lymphoid subsets in normal donors for allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Humanized CD52 monoclonal antibody campath-1H as first-line treatment in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

EX VIVO DEPLETION OF T CELLS FROM BONE MARROW GRAFTS WITH CAMPATH-1 IN ACUTE LEUKEMIA

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Selective depletion of CD8+ cells for prevention of graft-versus-host disease after bone marrow transplantation. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Comparative Outcomes of T-Cell–Depleted and Non–T-Cell–Depleted Allogeneic Bone Marrow Transplantation for Chronic Myelogenous Leukemia: Impact of Donor Lymphocyte Infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Hepatic dysfunction following T-cell-depleted allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Comparison of T-cell-depleted BMT and PBPCT with respect to chimerism, graft rejection, and leukemic relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Improved outcome with T-cell-depleted bone marrow transplantation for acute leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBT

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

HLA-identical sibling peripheral blood progenitor cell transplants (PBPCT).

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Immune reconstitution following allogeneic peripheral blood stem cell transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Cellular and Molecular Basis of the Protective Immune Response to Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Severe herpesvirus infections in an adolescent without natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Activation and function of natural killer cell responses during viral infections

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900079-5

7 January 2021

10.1016/S0955-3886(00)00079-5

Identifiers

DOI

1 reference

30 July 2017

1 reference